These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Comparison of immunogenicity of cell-and egg-passaged viruses for manufacturing MDCK cell culture-based influenza vaccines. Shin D, Park KJ, Lee H, Cho EY, Kim MS, Hwang MH, Kim SI, Ahn DH. Virus Res; 2015 Jun 02; 204():40-6. PubMed ID: 25892718 [Abstract] [Full Text] [Related]
5. Isolation of an Egg-Adapted Influenza A(H3N2) Virus without Amino Acid Substitutions at the Antigenic Sites of Its Hemagglutinin. Kuwahara T, Takashita E, Fujisaki S, Shirakura M, Nakamura K, Kishida N, Takahashi H, Suzuki N, Kawaoka Y, Watanabe S, Odagiri T. Jpn J Infect Dis; 2018 May 24; 71(3):234-238. PubMed ID: 29709975 [Abstract] [Full Text] [Related]
6. Evaluation of a qualified MDCK cell line for virus isolation to develop cell-based influenza vaccine viruses with appropriate antigenicity. Harada Y, Takahashi H, Fujimoto T, Horikoshi F, Chida S, Tanaka K, Minari K, Tanimoto Y, Fujisaki S, Miura H, Nakauchi M, Shimasaki N, Suzuki Y, Arita T, Hamamoto I, Yamamoto N, Hasegawa H, Odagiri T, Tashiro M, Nobusawa E. Vaccine; 2024 Oct 03; 42(23):126242. PubMed ID: 39213922 [Abstract] [Full Text] [Related]
8. Development of influenza A(H7N9) candidate vaccine viruses with improved hemagglutinin antigen yield in eggs. Ridenour C, Johnson A, Winne E, Hossain J, Mateu-Petit G, Balish A, Santana W, Kim T, Davis C, Cox NJ, Barr JR, Donis RO, Villanueva J, Williams TL, Chen LM. Influenza Other Respir Viruses; 2015 Sep 03; 9(5):263-70. PubMed ID: 25962412 [Abstract] [Full Text] [Related]
11. Development of a new candidate H5N1 avian influenza virus for pre-pandemic vaccine production. Dong J, Matsuoka Y, Maines TR, Swayne DE, O'Neill E, Davis CT, Van-Hoven N, Balish A, Yu HJ, Katz JM, Klimov A, Cox N, Li DX, Wang Y, Guo YJ, Yang WZ, Donis RO, Shu YL. Influenza Other Respir Viruses; 2009 Nov 03; 3(6):287-95. PubMed ID: 19903211 [Abstract] [Full Text] [Related]
13. Antigenicity of the 2015-2016 seasonal H1N1 human influenza virus HA and NA proteins. Clark AM, DeDiego ML, Anderson CS, Wang J, Yang H, Nogales A, Martinez-Sobrido L, Zand MS, Sangster MY, Topham DJ. PLoS One; 2017 Nov 03; 12(11):e0188267. PubMed ID: 29145498 [Abstract] [Full Text] [Related]
17. Effects of egg-adaptation on receptor-binding and antigenic properties of recent influenza A (H3N2) vaccine viruses. Parker L, Wharton SA, Martin SR, Cross K, Lin Y, Liu Y, Feizi T, Daniels RS, McCauley JW. J Gen Virol; 2016 Jun 03; 97(6):1333-1344. PubMed ID: 26974849 [Abstract] [Full Text] [Related]
19. The impact of key amino acid substitutions in the hemagglutinin of influenza A (H3N2) viruses on vaccine production and antibody response. Chen Z, Zhou H, Jin H. Vaccine; 2010 May 28; 28(24):4079-85. PubMed ID: 20399830 [Abstract] [Full Text] [Related]